Pony's death shines a light on drug use in equestrian sports

12/30/2012 | New York Times (tiered subscription model), The

Use of performance-enhancing drugs has been debated in horse racing circles for some time, and now the topic is being discussed in the equestrian world after the May 26 competition death of a pony cast a spotlight on the issue. This report identifies several weaknesses in oversight of drug use in equestrian animals, including the fact that while only veterinarians can administer drugs intravenously to racehorses, anyone can do so at horse shows, which are largely volunteer-run. However, the United States Equestrian Federation says it has worked to be proactive on the issue and has assembled a task force to investigate and find ways to tighten oversight.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX